share_log

国药现代(600420.SH):氨甲环酸注射液通过仿制药一致性评价

Sinopharm Hyundai (600420.SH): Tranexamic acid injection passed generic drug consistency evaluation

Gelonghui Finance ·  Mar 12 05:52

Gelonghui March 12 丨 Sinopharm Hyundai (600420.SH) announced that the holding subsidiary Shanghai Hyundai Hasson (Shangqiu) Pharmaceutical Co., Ltd. received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, approved tranexamic acid injections to increase product regulations and passed a consistent evaluation of the quality and efficacy of generic drugs. Blood medications up to tranexamic acid injections are mainly used for all kinds of bleeding caused by acute or slow, limited systemic hyperfibrinolysis.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment